Boltz-2 is the first biomolecular co-folding model to combine structure and binding affinity prediction, approaching the accuracy of physics-based free energy perturbation (FEP) calculations but at ...

Recursion has demonstrated the importance of scaled computation by developing groundbreaking new foundation models like Phenom-1, a deep-learning model designed to extract biologically meaningful ...

French startup Mistral AI announced the release of Large 2 today, its new flagship model that is significantly more capable of code generation, mathematics, and reasoning. Mistral has also added ...

Recursion shares jumped over 18% after launching Boltz-2, a breakthrough AI model with MIT that predicts molecular binding The open-source model significantly accelerates drug discovery, making ...

We recently published 12 Best Healthcare Stocks to Buy Under $30. Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) is one of the best healthcare stocks. Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) is a ...